CN Stock MarketDetailed Quotes

300363 Porton Pharma Solutions

Watchlist
  • 16.35
  • -0.13-0.79%
Market Closed Dec 27 15:00 CST
8.92BMarket Cap-22.77P/E (TTM)

Porton Pharma Solutions Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-33.88%1.4B
-40.23%1.48B
-34.38%1.81B
-31.01%1.97B
-34.42%2.12B
76.87%2.48B
79.00%2.75B
134.24%2.85B
149.70%3.23B
-0.16%1.4B
Notes receivable and accounts receivable
6.56%750.96M
-33.99%634.57M
-51.60%659.13M
-53.56%676.43M
-43.61%704.72M
-65.08%961.37M
9.83%1.36B
40.73%1.46B
67.35%1.25B
399.92%2.75B
-Accounts receivable
6.56%750.96M
-33.99%634.57M
-51.60%659.13M
-53.56%676.43M
-43.61%704.72M
-65.08%961.37M
9.83%1.36B
40.73%1.46B
67.35%1.25B
399.92%2.75B
Other receivables (including interest and dividends)
26.61%51.55M
-0.39%45.68M
-56.28%37.31M
-26.13%44.99M
-40.17%40.71M
-39.82%45.86M
-18.46%85.34M
-8.74%60.91M
73.99%68.05M
543.22%76.19M
-Other receivable
----
-0.39%45.68M
----
----
----
-39.82%45.86M
----
-8.74%60.91M
----
543.22%76.19M
Contractual assets
-34.01%5.89M
-56.58%5.89M
-75.05%4.23M
-69.50%8.07M
-47.70%8.92M
-1.97%13.57M
50.01%16.96M
-32.57%26.46M
--17.06M
--13.84M
Advance payment
-4.64%64.92M
-33.84%45.24M
-21.87%50.35M
-24.80%46.7M
33.52%68.08M
37.53%68.38M
36.05%64.45M
90.65%62.1M
50.31%50.99M
64.20%49.72M
Inventories
33.79%809.38M
38.33%780.71M
-1.93%671.21M
-20.52%717.07M
-43.93%604.95M
-47.86%564.38M
-30.24%684.4M
19.12%902.2M
72.17%1.08B
123.86%1.08B
Receivable financing
-41.01%14.34M
-15.27%15.99M
61.23%19.43M
-73.66%6.07M
238.11%24.31M
114.52%18.88M
103.35%12.05M
71.78%23.05M
331.60%7.19M
473.71%8.8M
Other current assets
31.77%105.24M
30.90%104.31M
285.07%192.7M
228.17%181.93M
-12.20%79.87M
68.15%79.68M
-13.95%50.04M
18.65%55.44M
-5.70%90.96M
-30.73%47.39M
Total current assets
-12.20%3.21B
-26.68%3.12B
-31.92%3.44B
-33.10%3.65B
-36.99%3.65B
-21.82%4.25B
26.52%5.05B
70.12%5.46B
101.29%5.8B
112.16%5.43B
Non Current assets
Other equity investment
----
----
----
----
----
----
--20M
----
----
----
Other non-current financial assets
58.12%39.61M
60.02%39.44M
--38.6M
--25.05M
--25.05M
--24.64M
----
----
----
----
Investment real estate
-3.99%4.22M
-3.95%4.27M
-4.73%4.31M
-3.88%4.35M
-3.84%4.4M
-3.80%4.44M
-9.27%4.52M
-3.73%4.53M
-3.70%4.57M
-3.66%4.62M
Long-term equity investment
-3.14%344.25M
-3.22%349.37M
-3.90%351.77M
-2.60%362.98M
-6.88%355.4M
-7.52%361M
-7.30%366.06M
-1.19%372.65M
5.02%381.64M
6.31%390.36M
Fixed assets
----
9.15%2.86B
----
----
----
34.30%2.62B
----
21.28%2.12B
----
21.78%1.95B
Constru in process
----
-2.62%756.23M
----
----
----
21.34%776.58M
----
201.25%1.03B
----
557.57%640.03M
Intangible assets
-0.28%267.63M
4.06%273.06M
2.96%272.3M
3.02%275.16M
5.68%268.37M
1.51%262.41M
62.84%264.48M
104.20%267.1M
90.31%253.93M
128.91%258.51M
Goodwill
-12.98%290.13M
-12.62%291.96M
-11.32%291.48M
-11.76%291.29M
0.37%333.42M
2.42%334.13M
17.39%328.69M
17.72%330.11M
19.27%332.19M
35.55%326.22M
Long deferred expense
2.39%410.03M
43.27%423.53M
165.16%420.84M
169.56%430.39M
370.15%400.45M
357.47%295.62M
153.55%158.71M
150.29%159.66M
--85.18M
--64.62M
Deferred tax assets
44.53%89.26M
32.96%94.11M
20.23%87.69M
18.94%74.68M
-14.59%61.76M
-11.39%70.78M
24.05%72.94M
6.57%62.79M
44.16%72.31M
123.50%79.88M
Usufruct assets
41.50%601.66M
50.73%612.95M
51.08%626.37M
177.70%643.78M
79.69%425.21M
78.32%406.66M
79.24%414.6M
2.25%231.82M
63.62%236.63M
47.79%228.05M
Other non current assets
-58.84%54.82M
-41.69%59.98M
-24.86%68.7M
-48.21%53.76M
-29.76%133.2M
-38.95%102.87M
-39.81%91.43M
-12.65%103.8M
78.53%189.64M
149.31%168.49M
Total non current assets
5.11%5.71B
9.61%5.76B
16.14%5.77B
22.38%5.73B
24.99%5.44B
27.90%5.26B
38.81%4.97B
39.71%4.68B
45.20%4.35B
53.31%4.11B
Total assets
-1.85%8.92B
-6.61%8.88B
-8.10%9.21B
-7.49%9.38B
-10.42%9.09B
-0.41%9.5B
32.33%10.02B
54.59%10.14B
72.70%10.15B
82.07%9.54B
Liabilities
Current liabilities
Short term loan
----
----
-95.31%10.01M
-93.40%20.03M
-95.36%20M
-33.33%120.55M
-19.61%213.36M
-22.15%303.35M
273.19%431.14M
521.80%180.81M
Notes payable and accounts payable
9.16%895.69M
-16.93%874.15M
-36.62%772.63M
-55.47%796.14M
-58.47%820.49M
-51.52%1.05B
-18.07%1.22B
60.92%1.79B
134.68%1.98B
221.53%2.17B
-Notes payable
30.56%378.76M
-49.01%256.61M
-67.72%249.33M
-80.49%224.22M
-80.46%290.11M
-62.45%503.31M
-0.69%772.27M
123.34%1.15B
288.88%1.48B
347.72%1.34B
-Accounts payable
-2.54%516.93M
12.48%617.54M
17.11%523.3M
-10.41%571.92M
7.92%530.38M
-33.88%549.04M
-37.10%446.84M
7.05%638.4M
6.79%491.47M
121.00%830.38M
Contract liabilities
21.99%83.32M
44.47%94.7M
42.87%104.92M
-21.91%57.5M
-27.63%68.3M
-28.17%65.55M
46.09%73.44M
15.63%73.63M
207.31%94.38M
367.33%91.25M
Salaries payable
-40.96%120.89M
-70.25%77.3M
-67.64%85.77M
-72.27%102.49M
-20.76%204.77M
32.86%259.81M
134.04%265.07M
118.71%369.54M
265.45%258.42M
222.04%195.56M
Taxs payable
-65.77%32.18M
-80.30%20.62M
-65.01%58.79M
-52.65%65.61M
14.40%94.02M
-38.36%104.72M
81.52%168.04M
118.96%138.56M
74.60%82.18M
650.76%169.89M
Other payable (including interest and dividends)
-15.97%73.93M
-38.17%63.06M
-45.78%78.95M
-35.47%79.61M
-70.73%87.98M
-67.15%101.99M
23.75%145.61M
25.49%123.37M
79.33%300.6M
-20.37%310.45M
-Other payable
----
-38.17%63.06M
----
----
----
-67.15%101.99M
----
25.49%123.37M
----
-20.37%310.45M
Non current liabilities due within one year
56.73%297.84M
65.35%274.14M
67.21%264.1M
160.97%261.42M
158.78%190.04M
225.59%165.79M
238.99%157.95M
-16.36%100.18M
-74.69%73.44M
-81.28%50.92M
Other current liabilities
-4.97%7.48M
-27.32%6.48M
74.39%10.66M
16.24%6.72M
-31.44%7.87M
-24.20%8.92M
16.00%6.11M
37.58%5.78M
198.12%11.48M
424.02%11.77M
Total current liabilities
-1.26%1.51B
-29.73%1.42B
-39.94%1.4B
-53.87%1.39B
-55.80%1.53B
-38.38%2.02B
2.22%2.33B
42.36%3.02B
107.70%3.46B
123.25%3.28B
Current liabilities
Long term loan
46.48%1.07B
59.00%1.08B
167.76%1.06B
242.06%1.07B
114.22%732.02M
-0.03%676.57M
-15.62%395.23M
1,203.80%312.91M
1,051.33%341.72M
1,806.45%676.79M
Estimate liabilities
----
----
----
----
----
----
----
----
--4.63M
--4.63M
Deferred tax liabilities
-21.98%54.89M
-2.09%64.38M
4.46%77.39M
29.10%91.04M
56.57%70.35M
153.19%65.76M
961.36%74.08M
805.28%70.52M
38.52%44.93M
-5.34%25.97M
Long term deferred income
32.76%137.97M
36.38%125.57M
72.28%115.5M
68.57%109.99M
68.04%103.92M
139.82%92.07M
84.32%67.04M
257.30%65.25M
474.45%61.84M
264.85%38.39M
Lease liabilities
50.67%592.48M
63.65%600.42M
63.30%612.7M
199.70%621.38M
82.38%393.23M
77.44%366.9M
75.80%375.2M
-0.00%207.33M
88.76%215.62M
47.11%206.78M
Total non current liabilities
42.95%1.86B
55.34%1.87B
104.47%1.86B
188.53%1.89B
94.32%1.3B
26.11%1.2B
25.70%911.55M
154.87%656.01M
257.41%668.74M
345.09%952.57M
Total liabilities
19.03%3.37B
1.96%3.29B
0.67%3.26B
-10.56%3.28B
-31.50%2.83B
-23.88%3.23B
7.89%3.24B
54.55%3.67B
122.81%4.13B
151.42%4.24B
Shareholders equity
Paid-in capital
-0.12%545.46M
-0.02%546.04M
0.02%546.04M
0.00%546.04M
0.32%546.12M
0.36%546.12M
0.33%545.96M
0.30%546.03M
0.05%544.37M
0.01%544.17M
Capital reserve funds
-0.27%2.05B
4.11%2.06B
4.74%2.06B
5.59%2.07B
5.95%2.05B
9.54%1.98B
9.43%1.97B
8.85%1.96B
12.14%1.94B
7.83%1.81B
Surplus reserve funds
0.00%273.02M
0.00%273.02M
0.00%273.02M
0.00%273.02M
31.24%273.01M
31.24%273.01M
31.24%273.01M
31.24%273.01M
51.44%208.03M
51.44%208.03M
Retained profit
-20.43%2.55B
-18.23%2.59B
-20.05%2.93B
-9.98%3.02B
7.12%3.21B
20.44%3.16B
92.43%3.66B
120.78%3.36B
109.51%2.99B
104.88%2.63B
Less:Treasury stock
9.94%129.85M
19.64%145.75M
3.35%135.27M
1.63%135.27M
47.09%118.11M
178.13%121.83M
122.44%130.89M
115.25%133.1M
51.68%80.3M
-42.09%43.8M
Other composite income
2,011.65%24.03M
-47.89%7.42M
-71.39%5.51M
583.45%29.24M
97.63%-1.26M
165.03%14.23M
267.11%19.26M
115.67%4.28M
-283.38%-53.06M
-59.84%-21.89M
Shareholders equity without minority interests
-10.86%5.31B
-8.98%5.33B
-10.39%5.68B
-3.37%5.8B
7.37%5.96B
14.34%5.86B
44.54%6.34B
50.77%6B
47.15%5.55B
44.20%5.12B
Minority interests
-19.72%241.08M
-39.41%254.39M
-39.28%270.5M
-36.23%299.17M
-35.51%300.3M
130.79%419.86M
138.67%445.45M
129.39%469.17M
86.45%465.65M
6,491.59%181.92M
Total shareholder equity
-11.29%5.55B
-11.01%5.59B
-12.29%5.95B
-5.75%6.1B
4.05%6.26B
18.33%6.28B
48.39%6.78B
54.61%6.47B
49.59%6.02B
49.20%5.31B
Total liabilityies and equity
-1.85%8.92B
-6.61%8.88B
-8.10%9.21B
-7.49%9.38B
-10.42%9.09B
-0.41%9.5B
32.33%10.02B
54.59%10.14B
72.70%10.15B
82.07%9.54B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -33.88%1.4B-40.23%1.48B-34.38%1.81B-31.01%1.97B-34.42%2.12B76.87%2.48B79.00%2.75B134.24%2.85B149.70%3.23B-0.16%1.4B
Notes receivable and accounts receivable 6.56%750.96M-33.99%634.57M-51.60%659.13M-53.56%676.43M-43.61%704.72M-65.08%961.37M9.83%1.36B40.73%1.46B67.35%1.25B399.92%2.75B
-Accounts receivable 6.56%750.96M-33.99%634.57M-51.60%659.13M-53.56%676.43M-43.61%704.72M-65.08%961.37M9.83%1.36B40.73%1.46B67.35%1.25B399.92%2.75B
Other receivables (including interest and dividends) 26.61%51.55M-0.39%45.68M-56.28%37.31M-26.13%44.99M-40.17%40.71M-39.82%45.86M-18.46%85.34M-8.74%60.91M73.99%68.05M543.22%76.19M
-Other receivable -----0.39%45.68M-------------39.82%45.86M-----8.74%60.91M----543.22%76.19M
Contractual assets -34.01%5.89M-56.58%5.89M-75.05%4.23M-69.50%8.07M-47.70%8.92M-1.97%13.57M50.01%16.96M-32.57%26.46M--17.06M--13.84M
Advance payment -4.64%64.92M-33.84%45.24M-21.87%50.35M-24.80%46.7M33.52%68.08M37.53%68.38M36.05%64.45M90.65%62.1M50.31%50.99M64.20%49.72M
Inventories 33.79%809.38M38.33%780.71M-1.93%671.21M-20.52%717.07M-43.93%604.95M-47.86%564.38M-30.24%684.4M19.12%902.2M72.17%1.08B123.86%1.08B
Receivable financing -41.01%14.34M-15.27%15.99M61.23%19.43M-73.66%6.07M238.11%24.31M114.52%18.88M103.35%12.05M71.78%23.05M331.60%7.19M473.71%8.8M
Other current assets 31.77%105.24M30.90%104.31M285.07%192.7M228.17%181.93M-12.20%79.87M68.15%79.68M-13.95%50.04M18.65%55.44M-5.70%90.96M-30.73%47.39M
Total current assets -12.20%3.21B-26.68%3.12B-31.92%3.44B-33.10%3.65B-36.99%3.65B-21.82%4.25B26.52%5.05B70.12%5.46B101.29%5.8B112.16%5.43B
Non Current assets
Other equity investment --------------------------20M------------
Other non-current financial assets 58.12%39.61M60.02%39.44M--38.6M--25.05M--25.05M--24.64M----------------
Investment real estate -3.99%4.22M-3.95%4.27M-4.73%4.31M-3.88%4.35M-3.84%4.4M-3.80%4.44M-9.27%4.52M-3.73%4.53M-3.70%4.57M-3.66%4.62M
Long-term equity investment -3.14%344.25M-3.22%349.37M-3.90%351.77M-2.60%362.98M-6.88%355.4M-7.52%361M-7.30%366.06M-1.19%372.65M5.02%381.64M6.31%390.36M
Fixed assets ----9.15%2.86B------------34.30%2.62B----21.28%2.12B----21.78%1.95B
Constru in process -----2.62%756.23M------------21.34%776.58M----201.25%1.03B----557.57%640.03M
Intangible assets -0.28%267.63M4.06%273.06M2.96%272.3M3.02%275.16M5.68%268.37M1.51%262.41M62.84%264.48M104.20%267.1M90.31%253.93M128.91%258.51M
Goodwill -12.98%290.13M-12.62%291.96M-11.32%291.48M-11.76%291.29M0.37%333.42M2.42%334.13M17.39%328.69M17.72%330.11M19.27%332.19M35.55%326.22M
Long deferred expense 2.39%410.03M43.27%423.53M165.16%420.84M169.56%430.39M370.15%400.45M357.47%295.62M153.55%158.71M150.29%159.66M--85.18M--64.62M
Deferred tax assets 44.53%89.26M32.96%94.11M20.23%87.69M18.94%74.68M-14.59%61.76M-11.39%70.78M24.05%72.94M6.57%62.79M44.16%72.31M123.50%79.88M
Usufruct assets 41.50%601.66M50.73%612.95M51.08%626.37M177.70%643.78M79.69%425.21M78.32%406.66M79.24%414.6M2.25%231.82M63.62%236.63M47.79%228.05M
Other non current assets -58.84%54.82M-41.69%59.98M-24.86%68.7M-48.21%53.76M-29.76%133.2M-38.95%102.87M-39.81%91.43M-12.65%103.8M78.53%189.64M149.31%168.49M
Total non current assets 5.11%5.71B9.61%5.76B16.14%5.77B22.38%5.73B24.99%5.44B27.90%5.26B38.81%4.97B39.71%4.68B45.20%4.35B53.31%4.11B
Total assets -1.85%8.92B-6.61%8.88B-8.10%9.21B-7.49%9.38B-10.42%9.09B-0.41%9.5B32.33%10.02B54.59%10.14B72.70%10.15B82.07%9.54B
Liabilities
Current liabilities
Short term loan ---------95.31%10.01M-93.40%20.03M-95.36%20M-33.33%120.55M-19.61%213.36M-22.15%303.35M273.19%431.14M521.80%180.81M
Notes payable and accounts payable 9.16%895.69M-16.93%874.15M-36.62%772.63M-55.47%796.14M-58.47%820.49M-51.52%1.05B-18.07%1.22B60.92%1.79B134.68%1.98B221.53%2.17B
-Notes payable 30.56%378.76M-49.01%256.61M-67.72%249.33M-80.49%224.22M-80.46%290.11M-62.45%503.31M-0.69%772.27M123.34%1.15B288.88%1.48B347.72%1.34B
-Accounts payable -2.54%516.93M12.48%617.54M17.11%523.3M-10.41%571.92M7.92%530.38M-33.88%549.04M-37.10%446.84M7.05%638.4M6.79%491.47M121.00%830.38M
Contract liabilities 21.99%83.32M44.47%94.7M42.87%104.92M-21.91%57.5M-27.63%68.3M-28.17%65.55M46.09%73.44M15.63%73.63M207.31%94.38M367.33%91.25M
Salaries payable -40.96%120.89M-70.25%77.3M-67.64%85.77M-72.27%102.49M-20.76%204.77M32.86%259.81M134.04%265.07M118.71%369.54M265.45%258.42M222.04%195.56M
Taxs payable -65.77%32.18M-80.30%20.62M-65.01%58.79M-52.65%65.61M14.40%94.02M-38.36%104.72M81.52%168.04M118.96%138.56M74.60%82.18M650.76%169.89M
Other payable (including interest and dividends) -15.97%73.93M-38.17%63.06M-45.78%78.95M-35.47%79.61M-70.73%87.98M-67.15%101.99M23.75%145.61M25.49%123.37M79.33%300.6M-20.37%310.45M
-Other payable -----38.17%63.06M-------------67.15%101.99M----25.49%123.37M-----20.37%310.45M
Non current liabilities due within one year 56.73%297.84M65.35%274.14M67.21%264.1M160.97%261.42M158.78%190.04M225.59%165.79M238.99%157.95M-16.36%100.18M-74.69%73.44M-81.28%50.92M
Other current liabilities -4.97%7.48M-27.32%6.48M74.39%10.66M16.24%6.72M-31.44%7.87M-24.20%8.92M16.00%6.11M37.58%5.78M198.12%11.48M424.02%11.77M
Total current liabilities -1.26%1.51B-29.73%1.42B-39.94%1.4B-53.87%1.39B-55.80%1.53B-38.38%2.02B2.22%2.33B42.36%3.02B107.70%3.46B123.25%3.28B
Current liabilities
Long term loan 46.48%1.07B59.00%1.08B167.76%1.06B242.06%1.07B114.22%732.02M-0.03%676.57M-15.62%395.23M1,203.80%312.91M1,051.33%341.72M1,806.45%676.79M
Estimate liabilities ----------------------------------4.63M--4.63M
Deferred tax liabilities -21.98%54.89M-2.09%64.38M4.46%77.39M29.10%91.04M56.57%70.35M153.19%65.76M961.36%74.08M805.28%70.52M38.52%44.93M-5.34%25.97M
Long term deferred income 32.76%137.97M36.38%125.57M72.28%115.5M68.57%109.99M68.04%103.92M139.82%92.07M84.32%67.04M257.30%65.25M474.45%61.84M264.85%38.39M
Lease liabilities 50.67%592.48M63.65%600.42M63.30%612.7M199.70%621.38M82.38%393.23M77.44%366.9M75.80%375.2M-0.00%207.33M88.76%215.62M47.11%206.78M
Total non current liabilities 42.95%1.86B55.34%1.87B104.47%1.86B188.53%1.89B94.32%1.3B26.11%1.2B25.70%911.55M154.87%656.01M257.41%668.74M345.09%952.57M
Total liabilities 19.03%3.37B1.96%3.29B0.67%3.26B-10.56%3.28B-31.50%2.83B-23.88%3.23B7.89%3.24B54.55%3.67B122.81%4.13B151.42%4.24B
Shareholders equity
Paid-in capital -0.12%545.46M-0.02%546.04M0.02%546.04M0.00%546.04M0.32%546.12M0.36%546.12M0.33%545.96M0.30%546.03M0.05%544.37M0.01%544.17M
Capital reserve funds -0.27%2.05B4.11%2.06B4.74%2.06B5.59%2.07B5.95%2.05B9.54%1.98B9.43%1.97B8.85%1.96B12.14%1.94B7.83%1.81B
Surplus reserve funds 0.00%273.02M0.00%273.02M0.00%273.02M0.00%273.02M31.24%273.01M31.24%273.01M31.24%273.01M31.24%273.01M51.44%208.03M51.44%208.03M
Retained profit -20.43%2.55B-18.23%2.59B-20.05%2.93B-9.98%3.02B7.12%3.21B20.44%3.16B92.43%3.66B120.78%3.36B109.51%2.99B104.88%2.63B
Less:Treasury stock 9.94%129.85M19.64%145.75M3.35%135.27M1.63%135.27M47.09%118.11M178.13%121.83M122.44%130.89M115.25%133.1M51.68%80.3M-42.09%43.8M
Other composite income 2,011.65%24.03M-47.89%7.42M-71.39%5.51M583.45%29.24M97.63%-1.26M165.03%14.23M267.11%19.26M115.67%4.28M-283.38%-53.06M-59.84%-21.89M
Shareholders equity without minority interests -10.86%5.31B-8.98%5.33B-10.39%5.68B-3.37%5.8B7.37%5.96B14.34%5.86B44.54%6.34B50.77%6B47.15%5.55B44.20%5.12B
Minority interests -19.72%241.08M-39.41%254.39M-39.28%270.5M-36.23%299.17M-35.51%300.3M130.79%419.86M138.67%445.45M129.39%469.17M86.45%465.65M6,491.59%181.92M
Total shareholder equity -11.29%5.55B-11.01%5.59B-12.29%5.95B-5.75%6.1B4.05%6.26B18.33%6.28B48.39%6.78B54.61%6.47B49.59%6.02B49.20%5.31B
Total liabilityies and equity -1.85%8.92B-6.61%8.88B-8.10%9.21B-7.49%9.38B-10.42%9.09B-0.41%9.5B32.33%10.02B54.59%10.14B72.70%10.15B82.07%9.54B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Biomedical
Biomedical
Intraday+0.69%
Virus Prevention
Virus Prevention
Intraday+0.51%
Innovative Drugs
Innovative Drugs
Intraday+0.47%